Euro watchdogs: Sanofi obstructed probe

Apparently it's an antitrust kind of day: The European Commission announced it's investigating Sanofi-Aventis for obstructing its big probe of anticompetitive tactics in the drug industry. Europe's antitrust watchdog was raiding Sanofi's HQ in France when company officials refused to release documents without a search warrant from the French government. European law, however, requires companies to comply with E.C. inspectors.

You'll recall that in January, the E.C.'s antitrust cops raided a number of drugmakers in January, looking for evidence that their behavior in patenting new drugs and suing generics makers may have dampened competition.

- see the E.C.'s release
- get the Dow Jones story for more

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.